X-chromosome inactivation generally results in dosage equivalence for expression of X-linked genes between 46,XY males and 46,XX females. The 20-30% of genes that escape silencing are thus candidates for having a role in the phenotype of Turner syndrome. Understanding which genes escape from silencing, and how they avoid this chromosome-wide inactivation is therefore an important step toward understanding Turner Syndrome. We have examined the mechanism of escape using a previously reported knock-in of a BAC containing the human escape gene RPS4X in mouse. We now demonstrate that escape from inactivation for RPS4X is already established by embryonic Day 9.5, and that both silencing and escape are faithfully maintained across the lifespan. No overt abnormalities were observed for transgenic mice up to 1 year of age despite robust transcription of the human RPS4X gene with no detectable downregulation of the mouse homolog. However, there was no significant increase in protein levels, suggesting translational compensation in the mouse. Finally, while many of the protein-coding genes have been assessed for their inactivation status, less is known about the X-linked RNA genes, and we propose that for many microRNA genes their inactivation status can be predicted as they are intronic to genes for which the inactivation status is known.
| INTRODUCTION
Sex-chromosome aneuploidies are the most common class of chromosome abnormality (Hall, Hunt, & Hassold, 2006) . Absence of a second sex chromosome (45,X) results in Turner syndrome (TS), although mosaicism, and/or a rearranged second sex chromosome are also commonly observed karyotypes. Prime candidates for the phenotype have therefore been genes shared by the X and Y sex chromosomes. The X and Y chromosomes were once homologous, but through the over 160 million years of evolution since the Y chromosome acquired sex-determining functionality, the majority of ancestral X/Y genes have been lost from the Y chromosome (reviewed in Graves, 2016) . As a result, females have two copies of most X-linked genes while males have one copy. This dosage difference is largely compensated for through silencing one X chromosome by X-chromosome inactivation (XCI). For those genes that retain Y homologs, expression from the inactive X (Xi) as well as the Y would be anticipated to lead to dosage equivalency between males and females. In male meiosis recombination between the X and Y chromosomes occurs in the Xp pseudoautosomal region (PAR1), keeping those genes equivalent between the sex chromosomes. The PAR1 genes escape from XCI, although studies have shown that males have higher expression of many of these genes than females, presumably because the copy on the Xi is expressed at lower levels than the Y copy (Tukiainen et al., 2017) . Interestingly, in the Xq PAR2 region genes on the Xi and Y chromosomes are silenced (De Bonis et al., 2006) . Outside of the PARs, humans retain expressed Y copies of 17 ancestral X-chromosomal genes (Bellott et al., 2014) , and 14 of these genes escape from XCI. In mice there is not as dramatic an impact for X monosomy; suggesting that the five Xi/Y expressed genes shared with mouse might be less impactful in TS phenotypic outcome.
In humans, 20-30% of X-linked genes escape XCI to some extent and continue to be expressed from the Xi (reviewed in [Balaton & Brown, 2016] ). The majority of these lack Y homologs, resulting in higher female than male expression (Tukiainen et al., 2017) . We have studied the genes that escape XCI to identify candidate genes for sex differences and to identify sequences important for epigenetic silencing. How can our studies inform the biology of Turner syndrome?
We have aggregated the data from multiple studies that used a variety of methodologies to assign XCI status to over 600 X-linked genes . Eighty genes (12% of those assessed) escape inactivation consistently while another 15% vary between individuals/studies or tissues. Thus, for TS causation, the list of Y candidates is more restrictive than the number of escapees ( Figure 1 ). As the limited list of X-Y candidates has yet to identify candidates for most of the TS phenotype, perhaps it is the lack of expression of the X-escapees that plays a sex-specific role that is lacking in TS females. Furthermore, a little is known about the somatic XCI status of the microRNA (miRNA) genes. However, they are reported to be enriched on the X chromosome and can have sex-specific expression patterns (e.g., [Florijn, Bijkerk, van der Veer, & van Zonneveld, 2018] ), therefore determining their XCI status might identify additional candidate genes for TS or sex-differences generally.
To identify elements involved in expression from the otherwise heterochromatic X chromosome we have studied the region including the RPS4X gene that escapes XCI in humans but not mice. We integrated a BAC containing the region into the mouse X-linked Hprt gene, and then crossed the knock-in mice with mice carrying a Xist-deletion to force the knock-in to be located on the Xi. The RPS4X gene, and the adjacent CITED1 gene continued to be expressed on the Xi in 8-10 week old mice, despite the mouse Rps4x gene normally being subject to XCI (Peeters, Korecki, Simpson, & Brown, 2018) . Thus, this region contains the necessary elements to be recognized as an escapee across species.
The RPS4X gene is from the long-arm of the human X chromosome, and genes on the Xq arm are likely poor candidates for involvement in TS, as isochromosome Xq is observed in over 15% of TS karyotypes (CameronPimblett, La Rosa, King, Davies, & Conway, 2017) . However, we believe that lessons learned from studying this escapee will inform our understanding of other escape genes, which are more likely TS candidates.
It has been proposed that many of the escapees have been selected to retain dosage equivalence between XX and XY individuals because of the role of the proteins in multi-protein complexes (e.g., [Pessia, Makino, Bailly-Bechet, McLysaght, & Marais, 2012] , reviewed in [Veitia, Veyrunes, Bottani, & Birchler, 2015] ). Additionally, members of multi-protein complexes (such as the ribosome) are more likely to be amongst thẽ 10% of proteins that undergo posttranslational dosage compensation (Ishikawa, Makanae, Iwasaki, Ingolia, & Moriya, 2017) . Thus, we have examined the levels of RPS4X protein in our mouse knock-in model. This model also provides the opportunity to address two long-standing question of escapee biology. First, is escape actually the result of reactivation of the gene early in development. In mouse, fewer genes constitutively escape XCI, and an early study on Kdm5c suggested that the gene was silenced before it was subsequently expressed from the Xi (Lingenfelter et al., 1998) , although more recent RNA-sequencing experiments have allowed the examination of additional mouse escapees and suggested the majority are continuously expressed from the Xi (Borensztein et al., 2017; Patrat et al., 2009 ). Second, is inactivation a source of variability with aging due to either reactivation of X-linked genes, or silencing of genes that normally escape (or variably escape) XCI.
| RESULTS

| Early RPS4X expression in mice
To address whether the escape from XCI that we observe reflects an early reactivation of the transgene, we dissected transgenic mouse embryos at embryonic Day (E) 9.5. The BAC transgene contained three genes, RPS4X and CITED1 that escape XCI and ERRC6L that is subject to XCI (Figure 2a) , that recapitulated the normal human expression pattern in the 8-10 week mouse knock-in (Peeters et al., 2018) . RPS4X showed clear expression from the Xi at this early embryonic stage, with levels detected by RT-qPCR~40% of the level seen from the Xa in male embryos ( Figure 2b ). No expression was observed for the tissue-specific CITED1 and ERRC6L genes, as at E9.5 tissues could not be dissected. We assessed DNA methylation using pyrosequencing to examine an average of at least three CpG sites in the CpG island promoters for RPS4X, CITED1, and ERRC6L as well as the flanking HPRT1 human/mouse chimaeric gene and the mouse Phf6 gene (Figure 2c ). RPS4X showed almost no DNA methylation, consistent with escape from XCI. The ERRC6L promoter showed significant methylation on the Xi relative to the low FIGURE 1 Schematic expression of genes from the X and Y chromosomes in 46,XX females (left), 46,XY males (right) and 45,X Turner syndrome (TS) females (center) to highlight candidate genes that may underlie the phenotype of TS. Arrows reflect classes of genes expressed from each sex chromosome. Orange: PAR1; green: Genes that escape from XCI; blue: Genes that are subject to XCI; gray: Y-specific genes, including ampliconic gene families. The purple arrow indicates XIST, which is expressed only from the Xi, while the red indicates SRY which is the male sex-determining gene. The difference between 46,XX and 45,X females are the escape genes (dotted green:~200 genes currently known to be expressed from the Xi) while the difference between 46,XY and 45,X are the genes expressed from the Y (dotted gray: 60 Y-linked genes or gene families). The overlap between these two classes is under 40 genes not expressed in 45,X that are expressed in both 46,XX and 46,XY methylation on the Xa, consistent with this gene being subject to XCI.
For CITED1, DNA methylation was significantly greater in the female than the male, and similar to what was observed previously for the adult liver and spleen. The presence of DNA methylation is consistent with CITED1 being a tissue-specific escape gene, and suggests that the gene is initially silenced, at least in the majority of the embryonic cells.
| Maintenance of inactivation status at 1 year timepoint
The BAC knock-in mice also provided an opportunity to address stability of silencing and escape with aging. We aged the mice for 1 year, then isolated multiple tissues for the assays described above to address whether the genes were maintaining their XCI status (Figure 2d, e) . RPS4X continued to be expressed from both the Xa and Xi, and was never observed to acquire DNA methylation, consistent with ongoing escape from XCI. CITED1 was only expressed in brain,
and similar to what we observed in 8-10 week old adult mice, the 1-year-old mice showed ongoing expression from the Xi. In the 8-10 week old mice the CITED1 promoter showed~10% DNA methylation, still within the range of DNA methylation seen for genes that escape XCI . Interestingly, despite ongoing expression in the 1-year brain, the DNA methylation had risen to~20%, comparable with the liver where expression was not detected. In the FIGURE 2 Analysis of BAC RP11-1145H7 shows RPS4X (and CITED1 in brain) escape XCI at Hprt across lifespan. (a) Integration of the RPS4X BAC at Hprt; genes on the BAC expected to escape from XCI in green, subject in blue, variable in yellow, and genes at integration site (both known to be subject to XCI) in gray. Genes with RT-qPCR and DNA methylation assays are indicated. Six mice for each genotype (transgenic male, transgenic female with completely skewed XCI, and transgenic female with random XCI) were analyzed at E9.5, and four mice for each genotype were analyzed at 1 year. (b) Normalized to Pgk1, RT-qPCR of RPS4X expression at E9.5 shows that the transgene is active on a male X, and escapes inactivation at 38% when on the Xi in females. Expression for an adjacent variable gene CITED1 was not detected. Expression from female Xi is shown as percentage of the male X (red text). (c) Average DNA methylation of skewed knock-in females shows a hypomethylated RPS4X promoter, with CITED1, ERCC6L, HPRT1, and Phf6 all significantly hypermethylated compared to knock-in males (Mann-Whitney t-test, significance from hypomethylated males denoted by asterisks; p-value < .001***, .001-.01**, .01-.05*, >.05 ns). (d) Normalized to Pgk1, RT-qPCR of RPS4X expression at 1 year shows that the transgene is active on a male X, and escapes inactivation at 50% when on the Xi in brain and liver and spleen. An adjacent discordant gene CITED1 also escapes from the Xi in females at~30% in brain only. CITED1 expression was not detected in liver and spleen. (e) Average DNA methylation of skewed knock-in females shows a hypomethylated RPS4X promoter in all tissues, with CITED1 having low DNA methylation yet still significantly hypermethylated along with ERCC6L, HPRT1, and Phf6 compared to knock-in males in all tissues liver and spleen where CITED1 was not expressed, elevated DNA methylation was observed in female, but not male. The ERCC6L gene was only expressed in mouse embryonic fibroblasts (MEFs) (Peeters et al., 2018) , and thus not surprisingly, we saw no expression at 1 year (data not shown), suggesting no tissues lost silencing of this gene. The ERCC6L DNA methylation was consistently high across tissues and, along with the flanking HPRT1 and Phf6 genes, showed no evidence for loss in DNA methylation over the year. In fact, methylation was generally higher than observed for the E9.5 embryo. The transgene is solely on the Xi in the 129-Xist 1lox /B6-Hprt RPS4X female mice, whereas in the 129-Xist wt /B6-Hprt RPS4X female mice skewing of XCI could contribute to altered levels of DNA methylation. Therefore, we examined expression of a gene that is polymorphic between the B6 and 129 X chromosomes to determine levels of skewing (Supporting Information Figure S1 ). There was a trend toward inactivating the B6 (transgenic) X chromosome in brain and spleen, with less skewing observed in liver. Overall, no change in XCI status was observed for the genes with age.
| Consequences of RPS4X expression in mice
Despite transcription of the RPS4X gene from both the Xa (in males and females) and the Xi (in females), no overt phenotype was detectable in the mice, nor was there any transmission distortion observed in our initial analysis (Peeters et al., 2018) . We aged the mice for a year to determine if there were any long-term consequences to RPS4X expression, and again observed no obvious phenotype in males or females. Furthermore, the mice have been bred to homozygosity and remain viable. Using MEFs, we examined the transcription of both the mouse Rps4x and the human (transgenic) RPS4X genes ( Figure 3a) . We did not observe any reduction in the amount of mouse Rps4x transcription due to the presence of the human RPS4X transcription. Posttranscriptional compensation, however, might regulate the dosage of protein.
To examine the level of protein in the presence of the human BAC knock-in, we used western blotting with antibodies to RPS4X in male lines with or without the transgene (Figure 3b ). To control for protein amounts we used a total protein stain (REVERT, see methods). Similar results were observed comparing to ACTB, or using a different RPS4X antibody (data not shown). Inter-gel variability precluded comparisons across all samples; however, within a gel, quadruplicate loadings of extracts from MEFs derived from a B6129F1-Hprt RPS4X male knock-in mouse (KI) or a B6129F1 line without the BAC knock-in (WT) were compared. No significant difference (unpaired t-test) was observed for two independent pairings of WT male versus KI male.
| Inactivation status of miRNA genes on the X chromosome
Our previous tabulation of escapees addressed~80% of proteincoding genes excluding the CTAG testis-specific gene family . However, an important category of X-linked genes for which we have little knowledge of XCI status is the miRNA genes.
Assessing the inactivation status of miRNA has several challenges.
First, they are often expressed at low levels or in only some tissues, including germ-line specific functions for some X-linked miRNA (Royo et al., 2015; Sosa, Flores, Yan, & McCarrey, 2015) . Second, their small size makes finding polymorphisms for allele-specific expression analysis unlikely. An alternative approach to examine Xi-expression has been to isolate the Xi and Xa separately in somatic-cell hybrids (Carrel & Willard, 2005) ; however, the miRNA would need to be expressed in the hybrids which are of fibroblast origin, and primers specific to the human (not mouse) must be used. There are over 100 miRNA on the X chromosome, with assignations varying between databases. Forty-four miRNA genes are intronic (and in the same orientation) to 21 X-linked protein-coding genes with XCI status (Table 1) . Thus, the miRNA should reflect the XCI status of the gene.
We directly examined three human miRNAs with divergence in sequence from the mouse in somatic cell hybrids by RT-qPCR (Supporting Information Figure S2 ). The MIR223 gene failed to be expressed in hybrids. MIR1184-1 was intronic to F8A1, a subject gene, and thus we would predict it would be subject to XCI, and indeed expression was only detected in the Xa-containing hybrid and not the Xi-containing hybrids. MIR424 was not intronic to a gene, but was also only expressed from the Xa, suggesting it is subject to XCI. Many of the genes retaining X/Y homology are escapees, and they have been argued to escape from XCI because they have extreme dosage-sensitivity and thus were selected to maintain Y and X expression (Naqvi, Bellott, Lin, & Page, 2018) . Such dosage-sensitivity has been attributed to critical gene regulatory roles (Bellott et al., 2014) or to genes that participate in multi-protein complexes (Pessia et al., 2012) .
The lack of increased protein, despite augmented RNA levels resulting from the human knock-in as well as the endogenous mouse Rps4x gene, is consistent with members of multi-protein complexes being more likely to undergo posttranslational dosage compensation (Ishikawa et al., 2017) . This compensation may underlie absence of a phenotype from the augmented RPS4X transcription in our mouse model. Posttranscriptional buffering would reduce the impact of gene dosage changes for
TS; yet, for the majority of X/Y conserved genes, there is evidence for evolutionarily conserved dosage sensitivity (Naqvi et al., 2018) .
Inter-individual variability in RPS4X expression in humans precluded us from determining whether similar posttranscriptional dosage compensation occurs with loss or gain of the X chromosome.
We were, however, able to observe different levels of protein between individuals and upon shRNA knock-down (data not shown),
suggesting that if posttranscriptional buffering occurs in humans, it is not stringent. In addition, altered protein levels of RPS4X have been reported in cancer (Tsofack et al., 2013) .
Many of the X/Y conserved escapees are chromatin regulators or transcriptional regulators (Bellott et al., 2014) , and they have been proposed to be involved in establishing sex-specific expression and chromatin balance even before expression of SRY (reviewed in [Engel, 2018] ). It may be that against this sex-specific background the lack of an X (and the escapees expressed from it) in females contributes to the phenotype of TS. As miRNA genes have been reported to show sexspecific expression (e.g., [Florijn et al., 2018] ) and have generally not been examined for XCI status, we determined that a substantial proportion of X-linked miRNA genes are intronic to protein-coding genes and could have candidate XCI statuses derived from their encompassing gene. This analysis suggests that eight miRNA genes located within escapees are candidate escapees, with another four being found within variable escape genes that differ in XCI status between individuals or tissues. These inferred inactivation statuses do not account for internal promoters, which may contribute to the tissue-specific transcription seen for miRNAs. While escapees do cluster together, there are isolated escape genes, and even alternative promoters that have been suggested to have different XCI statuses (Goto & Kimura, 2009 ).
Beyond escapees, there are considerable other differences that could contribute to TS (Figure 1 ). There is a disruption in chromosome number and substantial changes in the amount of DNA. The XIST gene is uniquely expressed from the Xi, and the heterochromatin of the Xi could serve as a sink for proteins involved in silencing (Blewitt et al., 2005) . However, the similar phenotype observed with TS patients TABLE 1 X-linked microRNA (MIR) genes with known X inactivation status, or that are within, and in the same orientation as, other genes on the X (listed as gene intronic). The assigned inactivation status is generally derived from the inactivation status of the gene harboring the miRNA. MIR223, MIR424 and MIR1184-1 were examined in hybrids (see Supplemental Figure 2 ) Confirmed subject to XCI in hybrids (Supplemental Figure 2 and Carrel and Willard, 2005) with an isochromosome (which is large and inactive) diminish the likelihood of many of these contributions. Transcriptome and DNA methylation profiling of X-chromosome aneuploids reveals both X-linked and autosomal changes to the epigenetic landscape and transcriptional network (Skakkebaek et al., 2018; Trolle et al., 2016 ), yet the considerable variability amongst humans makes monitoring changes across time and across tissues challenging. Mice have fewer escape genes than humans, and PAR1 shares little homology between humans and mice (Raudsepp & Chowdhary, 2016) , reducing the ability of mouse to model TS. However, we have demonstrated that escape from XCI of human-specific escapees can be recapitulated in the mouse, allowing us to utilize mouse to examine escapee biology. This mouse model has provided us access to developmental timepoints confirming that RPS4X constitutively escapes XCI across the lifespan.
| METHODS
| Transgenic mouse model generation
Creation and breeding of the RPS4X knock-in mouse was previously reported (Peeters et al., 2018) . according to the manufacturer's protocol, using 10-15 μL of PCR products. CDT tips were used to dispense the nucleotides for pyrosequencing, using the PyroMark MD machine (Qiagen, Venlo, Netherlands).
| Expression analysis
Each human promoter assay was tested in at least one mouse sample without the target transgene to ensure the specificity of the human primers. At least three CpGs in an island were evaluated and averaged per assay. Significance was tested using the Mann-Whitney t-test in GraphPad Prism 5. Pyrosequencing was performed as above using primers that amplify a single-nucleotide polymorphism of the Flna locus from gDNA and cDNA of knock-in females without the Xist deletion to determine level of skewing by relative expression of the B6 and 129 alleles (Supporting Information Table 1 for primer information).
| miRNA expression analysis
RNA was extracted from somatic cell hybrids using TRIzol (Invitrogen) and treated with DNase I (Roche) according to the companies' protocols. Reverse-transcription was done using M-MLV RT (Invitrogen).
Expression levels of MIR223, MIR1184-1, and MIR424 were examined by RT-qPCR using GoTaq G2 Hot Start Polymerase (Promega) and EvaGreen (Biotium) under the same cycling conditions as above (Supporting Information Table 1 for primer information).
| Cell culture
Hybrid cell lines (Xi-containing t86-B1maz1b-3a [t86], t75-2maz34-4a 
